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The Clinical Frailty Scale predicts inpatient 
mortality in older hospitalised patients with 
idiopathic Parkinson’s disease
KM Torsney1,3, R Romero-Ortuno2,3
Parkinson’s disease and frailty are both common conditions affecting older 
people. Little is known regarding the association of the Clinical Frailty Scale 
with hospital outcomes in idiopathic Parkinson’s disease patients admitted 
to the acute hospital. We aimed to test whether frailty status was an 
independent predictor of short-term mortality and other hospital outcomes 
in older inpatients with idiopathic Parkinson’s disease.
Method We conducted an observational retrospective study in a large tertiary university 
hospital between October 2014 and October 2016. Routinely measured patient characteristics 
included demographics (age and sex), Clinical Frailty Scale, acute illness severity (Emergency 
Department Modi ed Early Warning Score), the Charlson Comorbidity Index, discharge 
specialty, history of dementia, history of depression and the presence of a new cognitive 
impairment. Outcomes studied were inpatient mortality, death within 30 days of discharge, 
new institutionalisation, length of stay ≥ 7 days and readmission within 30 days to the same 
hospital. 
Results There were 393  rst admission episodes of idiopathic Parkinson’s disease patients 
aged 75 years or more; 166 (42.2%) were female. The mean age (standard deviation) was 82.8 
(5.0) years. The mean Clinical Frailty Scale was 5.9 (1.4) and the mean Charlson Comorbidity 
Index was 1.3 (1.5). After adjustment for covariates, frailty and acute illness severity were 
independent predictors of inpatient mortality; odds ratio for severely/very severely frail or 
terminally ill = 8.1, 95% con dence interval 1.0–63.5, p = 0.045 and odds ratio for acute 
illness severity: 1.3, 95% con dence interval 1.1–1.6, p = 0.005). The Clinical Frailty Scale did 
not signi cantly predict other hospital outcomes.
Conclusions The Clinical Frailty Scale was a signi cant predictor of inpatient mortality in 
idiopathic Parkinson’s disease patients admitted to the acute hospital and it may be useful 
as a marker of risk in this vulnerable population. 
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Abstract
Introduction
Idiopathic Parkinson’s disease (PD) is a neurodegenerative 
disorder that affects 1–2% of the UK population > 65 
years, and is characterised by bradykinesia, tremor, rigidity, 
postural instability and a myriad of non-motor manifestations. 
PD patients vary in the way motor function and disability 
worsens over time. The hospital outcomes of PD patients 
are variable and having predictive tools may be important to 
inform discussions with patients and relatives, and possibly 
to help decision making about treatment escalation options.
Frailty is a state of increased vulnerability to stressors, caused 
by impaired homeostasis and loss of reserve across multiple 
physiological systems.1 The two main validated methods to 
measure frailty in older people are the phenotype model (i.e. 
three or more of the following: exhaustion, unexplained weight 
loss, low handgrip strength, low gait speed and low physical 
activity), and the accumulation of defi cits (i.e. proportion of 
health defi cits – symptoms, signs, comorbidities, disabilities 
and/or laboratory defi cits – that are present in a patient 
out of a list of 30–70 items). Another validated frailty tool 
is the Clinical Frailty Scale (CFS), which is based on clinical 
judgement.2 The CFS is a tool that correlates well with the 
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two main measures of frailty. It does not really measure the 
construct of frailty itself but because it correlates well and 
is easy to use, it may be a useful tool for clinical practice.
PD and frailty are both prevalent in older people and may 
underpin a situation of clinical vulnerability. In PD patients, 
gradual decline in motor and non-motor physiological systems 
may give rise to frailty, but PD is by no means a synonym of 
frailty. A previous study with 50 PD patients showed that the 
phenotype of frailty is more prevalent in PD patients, but their 
clinical picture may overlap.3
There has been very little research on frailty in PD, and 
previous reports have focused on the frailty phenotype.3–6 To 
our knowledge, no studies have addressed the associations 
of the CFS with the outcomes of PD patients admitted to the 
acute hospital. We aimed to test whether frailty status was 
an independent predictor of short-term mortality and other 
hospital outcomes in older inpatients with PD.
Methods
Study population
We conducted a retrospective observational study in a 
large tertiary university hospital in England. We analysed all 
emergency admission episodes of patients with PD aged over 
74 (in all specialities) between October 2014 and October 
2016. Data were obtained via the hospital’s electronic patient 
records. Only fi rst admissions were analysed. PD patients 
were identifi ed based on discharge diagnosis (made prior to 
admission or during admission by a senior clinician). 
Clinical Frailty Scale
Since 2013, our hospital has routinely collected the CFS 
in patients aged over 74 admitted non-electively to the 
hospital.7 The 9 levels of the CFS are: 1: very fi t; 2: fi t; 3: 
managing well; 4: vulnerable; 5: mildly frail; 6: moderately 
frail; 7: severely frail; 8: very severely frail; 9: terminally ill.8 
The admitting medical team scores the patient, making a 
judgment about the degree of a person’s baseline frailty (i.e. 
prior to the onset of the acute illness triggering the admission) 
based on information from the initial clinical assessment. The 
CFS is collected electronically. The CFS and other covariates 
were extracted for the purpose of service evaluation from the 
hospital’s electronic patient records.
Patient characteristics
Other routinely collected anonymised patient characteristics 
included demographics (age and sex), discharge specialty, 
the presence of dementia, a new cognitive impairment, 
depression (based on established clinical diagnosis), the 
Charlson Comorbidity Index (CCI), and acute illness severity 
on admission as per the Emergency Department Modifi ed 
Early Warning Score (ED-MEWS). In our hospital, patients 
aged over 74 admitted non-electively undergo a routine 
assessment for delirium and dementia.7 In our analyses, 
dementia refers to a known, previously diagnosed dementia; 
and new cognitive impairment refers to an abnormal 4-item 
Abbreviated Mental Test (at least one error in date of birth, 
age, place, year), or a clinically identifi ed acute confusional 
state, in the absence of a previously diagnosed dementia.
Outcomes
The following outcomes were extracted from the hospital’s 
electronic patient records: inpatient mortality, prolonged 
length of stay (LoS) (≥ 7 days), new institutionalisation, death 
within 30 days post-discharge, and readmission within 30 
days. New institutionalisation was defi ned as discharge to 
a residential or nursing home when this was not the usual 
place of residence on admission. For readmissions, we only 
looked for readmission to the same hospital. Our hospital’s 
electronic patient records system is routinely linked to the 
NHS Spine (https://digital.nhs.uk/spine) and this is how the 
hospital knows if someone dies within 30 days of discharge.
Statistical analysis
Anonymised data were analysed using IBM SPSS v23 (IBM, 
New York, USA). Descriptives are given as count (with 
percentages, %), mean (with standard deviation, SD) or 
median (with interquartile range, IQR). Multivariate analyses 
were based on binary logistic regression. The method for 
the logistic regressions was stepwise forward selection. 
Due to low numbers, we categorised the CFS as follows: 
1–4 (i.e. up to vulnerable) as the reference (non-frail) 
category, 5–6 as mild-moderate frailty, and 7–9 as severe, 
very severe frail or terminally ill. In the description of the 
CFS, the word ‘frail’ does not appear until category 5 (i.e. 
‘mildly frail’). In the multivariate logistic regression models, 
the following variables were entered on step one: age, sex, 
CFS categories, ED-MEWS, CCI, new cognitive impairment, 
depression and dementia. 
The level of statistical signifi cance for bivariate comparisons 
and multivariate predictors was set at p < 0.05. P values 
were 2-tailed. 
Ethics
This service evaluation audit was registered with our centre’s 
Safety and Quality Support Department (project register 
number 3962/6708). Formal confi rmation was received that 
Ethics Committee approval was not required.
Results
Between October 2014 and October 2016, there were 393 
fi rst admission episodes of PD patients aged over 74 years, 
of which 166 (42.2%) were female. The mean age (SD) 
was 82.8 (5.0). Other patient characteristics including the 
distribution of CFS scores and the hospital outcomes are 
summarised in Table 1.
The results of the multivariate regression models in Table 
2 suggest that, after adjustment for covariates, frailty was 
an independent predictor of inpatient mortality: odds ratio 
(OR) for severely/very severely frail or terminally ill: 8.1, 95% 
confi dence interval (CI) 1.0–63.5, p = 0.045. The CFS did not 
signifi cantly predict other hospital outcomes.
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The other signifi cant predictor of inpatient mortality was acute 
illness severity on admission (OR for acute illness severity: 
1.3, 95% CI 1.1–1.6, p = 0.005). In this sample of PD 
patients, new cognitive impairment was a signifi cant predictor 
of death within 30 days of discharge (OR 8.7, 95% CI 3.2, 
23.6, p < 0.001) and LoS ≥ 7 days (OR 24.2, 95% CI 7.3–
79.8, p < 0.001). Dementia predicted new institutionalisation 
upon discharge (OR 2.9, 95% CI 1.6–5.3, p < 0.001), and CCI 
was a signifi cant predictor of readmission within 30 days of 
discharge (OR 1.4, 95% CI 1.1–1.6, p = 0.002).
Discussion
To our knowledge, our study was the fi rst to look at the 
association of the CFS with hospital outcomes in older PD 
patients. In our sample of 393 PD patients with a mean 
age of 83, the prevalence of patients classifi ed as at least 
mildly frail (84%) was much higher than the prevalence of 
33% previously reported with the frailty phenotype in an 
ambulatory sample of PD patients.3 Additionally, a third of our 
sample were severely frail or worse. Previously, studies have 
shown that in community-dwelling older adults, the prevalence 
of frailty by the CFS is known to be higher than that by the 
frailty phenotype.9
The prevalence of frailty using the CFS in our PD sample was 
also higher than that reported in the overall population of 
patients aged over 74 years admitted in our hospital (57%).7 
A possible reason for this is that PD and frailty may have 
a shared underlying pathophysiology. Indeed, it has been 
argued that in PD, many motor and non-motor symptoms are 
diffi cult to explain in terms of a purely ascending degeneration 
process, and dysregulation in many other physiological 
systems may be implicated in the physiopathology.10 Another 
Table 1 Sample characteristics
Patient characteristics
Age: mean (SD) 82.8 (5.0)
Male
Female
227/393 (57.8%)
166/393 (42.2%)
Charlson Comorbidity Index
Median (IQR) 1.0 (2.0)
Clinical Frailty Scale score
Median (IQR)
1: very fi t
2: fi t
3: managing well
4: vulnerable
5: mildly frail
6: moderately frail
7: severely frail
8: very severely frail
9: terminally ill
6.0 (2.0%)
1/393 (0.3%)
5/393 (1.3%)
20/393 (5.1%)
37/393 (9.4%)
68/393 (17.3%)
131/393 (33.3%)
98/393 (24.9%)
22/393 (5.6%)
11/393 (2.8%)
Known dementia
New cognitive impairment
82/393 (20.9%)
59/393 (15.0%)
Depression 30/393 (7.6%)
Maximum ED-MEWS
Median (IQR) 2.0 (2.0)
Discharge ward: General Medicine 117/393 (29.8%)
Discharge ward: Geriatric Medicine 145/393 (36.9%)
Patient outcomes
Inpatient death (%) 28/393 (7.1)
Length of stay
Median (IQR)
Length of stay ≥ 7 days
7.0 (14.0)
199/393 (50.6%)
Discharge to usual place of 
residence
257/393 (65.4%)
New institutionalisation 66/393 (16.8%)
Death within 30 days post-discharge 20/393 (5.1%)
Readmission within 30 days 47/393 (12.0%)
PD: Parkinson’s disease; SD: standard deviation; IQR: i nterquartile 
range; ED-MEWS: emergency department modifi ed early warning 
score.
Table 2  Multivariate predictors of outcomes in Parkinson’s disease 
patients
Odds ratio 
(OR) with 95% 
CI for OR
p
Inpatient mortality
CFS 1–4: up to vulnerable – 0.008
CFS 5–6: mildly/
moderately frail
2.46 (0.30, 
20.22)
0.402
CFS 7–9: severely/very 
severely frail/terminally ill
8.14 (1.04, 
63.45)
0.045
ED-MEWS (per point) 1.30 (1.08, 
1.56)
0.005
Death within 30 days of discharge
New cognitive impairment 8.70 (3.21, 
23.61)
<0.001
New institutionalisation
Dementia 2.90 (1.63, 
5.17)
<0.001
Length of stay ≥ 7 days
Age (per year) 1.05 (1.00, 
1.10)
0.034
Female sex 1.62 (1.03, 
2.54)
0.037
New cognitive impairment 24.21 (7.34, 
79.84)
<0.001
Readmission within 30 days
CCI (per point) 1.35 (1.12, 
1.63)
0.002
CFS: Clinical Frailty Scale; ED-MEWS: Emergency Department mod-
ifi ed Early Warning Score; CCI: Charlson Comorbidity Index
In the multivariate logistic regression models, the following variables 
were entered on step one: age, sex, CFS categories, ED-MEWS, CCI, 
new cognitive impairment, depression and dementia. 
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reason for the higher prevalence of frailty in PD may be that 
an acute illness presentation could exacerbate PD symptoms, 
giving the assessor a worse impression of the patient’s 
functional baseline, and therefore patients may be allocated 
a higher frailty score than they deserve. The latter hypothesis 
merits prospective investigation. 
Our results suggest that in our context the CFS may be valid 
in the ≥ 75 year age group as a predictor of inpatient mortality 
and death within 30 days of discharge, which strengthens 
the argument for increased awareness of diagnosis and 
treatment of frailty in this patient group. The association with 
post-discharge mortality should be understood in light of that 
fact that our patients with reduced life expectancy can access 
continuing healthcare funding for end-of-life care outside the 
hospital.11 Thirty-three percent of our sample were severely 
frail or more. These patients are a high-risk group and may 
benefi t from an early palliative care review, advance care 
planning and a focus on end-of-life care. 
The presence of a new cognitive impairment in our sample of 
PD patients was very strongly associated with prolonged LoS 
and death within 30 days of discharge. Delirium is known to 
carry a poor prognosis in terms of morbidity and mortality. In 
PD, systemic infl ammation frequently occurs in the context 
of an acute illness, which often results in delirium in the 
advanced stages of the disease.12 Delirium in turn can lead 
to cognitive and functional decline, institutionalisation, and 
mortality, especially in older people. The early identifi cation 
and management of delirium during hospital admission may 
prevent a prolonged LoS and complications, including, but 
not limited to, medication errors, falls, fractures and chest 
infections. To help achieve this, PD patients who are frail may 
benefi t from early transfer to wards that operate a model 
of comprehensive geriatric assessment,7 early supported 
discharge and a review by a PD specialist nurse.
Dementia was a moderate predictor of institutionalisation 
upon discharge. The rate of institutionalisation in our cohort 
was 16.8%, which is relatively high in comparison to the 
overall (hospital-wide) institutionalisation rate in patients 
over 74 years old (9.9%).13 This may refl ect the high clinical 
complexity of older PD patients requiring admission to our 
hospital. This is also consistent with previous observations 
that the progressive nature of PD often results in patients 
seeking long term care sooner than non-PD patients.4 Early 
recognition and management of dementia and delirium in 
PD may minimise functional decline during the hospital stay 
and may in turn reduce LoS and delay institutionalisation. 
It has been proposed that the CCI may be the optimum scale 
for measuring comorbidity burden in PD patients.14 However, 
in our analyses CCI was not associated with mortality. This 
may be due to the older nature of our sample, as previous 
studies have demonstrated that a greater association of the 
CCI with mortality was found within the fi rst four years of 
diagnosis with no signifi cant association thereafter.14 The 
fact that the CCI was a predictor of 30-day readmission rate 
is in keeping with previous analyses.7
Our study had several strengths. It had a relatively large 
sample size. Previous studies looking at frailty in PD used 
smaller samples of 15–50 patients.3–5 No previous study 
had used the CFS when investigating frailty in PD patients. 
In using the CFS, we may capture more symptomatic and 
functional aspects providing a more detailed insight into 
frailty in PD. Our fi ndings provide new information about 
frailty in PD and the need for further research and vigilance, 
especially surrounding delirium and dementia in this group 
of patients. 
Our study had major limitations, including its single-centre, 
retrospective observational design. Therefore, causality and 
external validity cannot be inferred from our study. Another 
limitation was that our database did not include information 
on the severity of PD according to the Unifi ed Parkinson’s 
Disease Rating Scale, and the inclusion of this variable in 
the model may have changed results. 
It is challenging to identify frailty in PD due to its presentation 
and diffi cult to know how best to assess frailty in these 
patients, but early identifi cation could enhance quality of life 
and may delay or reverse frailty-associated dependencies. 
It may be useful to know a patient’s frailty score, using the 
e-Frailty Index score collected in the primary care setting, 
when conducting future studies as this is not affected by 
acute illness at time of admission. These patients could 
then be targeted early to prevent frailty progressing and thus 
in turn potentially prevent negative hospital outcomes when 
they are admitted.
There is a need for further research into the usefulness of 
geriatric evaluation for the identifi cation of frailty in PD, for 
improving care and treatment in this multifaceted disease. 
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